Health
AstraZeneca vaccine trial hold leaves US participants in limbo – STAT
Experts say there’s no need to worry about this group or their data, because such trials are designed to account for such situations.
For the 20-something-year-old Hispanic man, volunteering for AstraZenecas Phase 3 Covid-19 vaccine study was an easy decision. His father, after all, had been briefly hospitalized with Covid-19, and, even beyond that personal motivation, signing up was the right thing to do, he told STAT.
The clinical trial participant, who lives in the western U.S., got his first shot in early September he doesnt know if he got the actual vaccine or a saline placebo, in line with the studys double-blinded desi…
-
General20 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General22 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News22 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
General21 hours agoLithium mine closure shines light on Ravensthorpe community’s resilience